Skip to content
AnalystLens

ARCH CAPITAL GROUP LTD. 8-K Report, Executive Changes (Feb 6, 2025)

Reports
Leadership Changes·Other Events·Exhibits & Filings
Filing Date
Filed February 6, 2025
Period End
February 4, 2025
Securities
ACGLACGLNACGLO
In the record · 2016–202610-K1110-Q328-K172

ACGL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 172 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Nov ’19Nov ’19
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Material agreement8-K · Jun ’26Jun ’26

Summary

Summary of the 8-K filed February 6, 2025. Cited figures are marked; the original filing is the authoritative source.

Arch Capital Group Ltd. (NASDAQ: ACGL) filed a Form 8-K on February 6, 2025 to disclose the appointment of Alexander "Alex" Moczarski as a Class III director of its Board of Directors, effective February 4, 2025.

The Board unanimously approved the appointment. Mr. Moczarski has not yet been assigned to any Board committee, and the filing states there are no arrangements or related-party transactions requiring disclosure. He will receive the same cash and equity compensation as ACGL's other non-employee directors.

The filing is a routine governance event with no reported impact on financial results, capital, guidance, or operations. Mr. Moczarski brings more than 45 years of global insurance experience, including prior leadership roles at Marsh McLennan (where he was Chairman of Marsh McLennan International), Guy Carpenter, and AIG, and he chaired Marsh India from 2016 to 2025. Management framed the addition as strengthening the Board's insurance expertise and international perspective as Arch continues to establish itself as a market leader.

For investors, the key takeaway is that this is an incremental board refresh focused on industry knowledge and global distribution insight rather than a strategic shift. The filing does not disclose the reasons for the appointment beyond the press release commentary, nor does it indicate any change in executive leadership. Investors should monitor future proxy disclosures for Mr. Moczarski's committee assignments and any changes to board composition.

Key Highlights

  1. Alexander Moczarski appointed as a Class III director of ACGL's Board, effective February 4, 2025, approved unanimously by the Board.
  2. Mr. Moczarski has not been assigned to any Board committee at this time.
  3. No arrangements or understandings with other persons for his selection, and no Item 404(a) related-party transactions disclosed.
  4. He will receive the same cash and equity compensation as ACGL's other non-employee directors, per the 2024 proxy statement's 'Director Compensation' section.
  5. Background: over 45 years of global insurance experience, formerly Chairman of Marsh McLennan International, with prior roles at Guy Carpenter, Marsh, and AIG; chaired Marsh India 2016–2025.
  6. Press release issued February 6, 2025 (Exhibit 99.1); CEO Nicolas Papadopoulo and Board Chair John Pasquesi endorsed the appointment.
  7. No financial results, capital, or guidance impact disclosed; ACGL cited approximately $25.0 billion in capital as of September 30, 2024.

Frequently Asked Questions

  1. Who was appointed to Arch Capital's Board of Directors?

    Alexander 'Alex' Moczarski was appointed as a Class III director, effective February 4, 2025. He previously served as Chairman of Marsh McLennan International and has over 45 years of global insurance experience.

  2. Does this appointment involve any related-party transactions or special compensation arrangements?

    No. The filing states Mr. Moczarski is not party to any Item 404(a) related-party transaction and has received no special grant or award tied to his selection. He will receive the standard compensation paid to ACGL's non-employee directors.

  3. Is Mr. Moczarski serving on any Board committees?

    Not at this time. The filing states he has not been appointed to any Board committee, so future committee assignments may be disclosed later.

  4. Does this appointment signal a change in Arch's strategy or leadership?

    The filing does not indicate a strategic or executive leadership change. Management's comments describe the addition as supporting the Board's insurance expertise and international perspective as Arch continues to grow as a market leader.

  5. Does this 8-K affect Arch's financial results or outlook?

    No financial results, guidance, or capital changes are reported in this filing. It is a governance disclosure only.